Soliton Inc. (SOLY)
NASDAQ: SOLY
· Real-Time Price · USD
22.58
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Company Description
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform.
The company offers products for the removal of tattoos.
It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications.
The company was incorporated in 2012 and is based in Houston, Texas.
As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
Soliton Inc.
| Country | United States |
| IPO Date | Feb 19, 2019 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Christopher C. Capelli |
Contact Details
Address: 5304 Ashbrook Dr Houston, Texas United States | |
| Website | https://www.soliton.com |
Stock Details
| Ticker Symbol | SOLY |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001548187 |
| CUSIP Number | 834251100 |
| ISIN Number | US8342511008 |
| Employer ID | 36-4729076 |
| SIC Code | 3841 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 28, 2021 | 15-12B | Filing |
| Dec 21, 2021 | EFFECT | Filing |
| Dec 21, 2021 | EFFECT | Filing |
| Dec 21, 2021 | EFFECT | Filing |
| Dec 20, 2021 | SC 13D/A | [Amend] Filing |
| Dec 17, 2021 | 4 | Filing |
| Dec 17, 2021 | 4 | Filing |
| Dec 17, 2021 | 4 | Filing |
| Dec 17, 2021 | 4 | Filing |
| Dec 17, 2021 | 4 | Filing |